The fund plans to support the 10 projects, including 4 in basic research, 5 in clinical and epidemiological research, and 1 in advanced therapy development.

Delayed diagnosis is a common challenge faced by patients with homozygous familial hypercholesterolemia (HoFH). Due to the rarity of the disease, limited awareness at the primary healthcare level, ...

From September 19 to 21, 2025, the inaugural Familial Hypercholesterolemia (FH) Conference and Patient Exchange Meeting, initiated and hosted by the Homy FH China Patient Network with collaborative...

Following the successful conclusion of The 1st Chinese Conference on Familial Hypercholesterolemia on September 20, FH China Patient Network thoughtfully planned a warm and heartfelt city tour of W...

On September 20, 2025, The 1st Chinese Conference on Familial Hypercholesterolemia initiated and hosted by FH China Patient Network with collaborative support from CORD (Chinese Organization for Ra...

At 7:00 PM on September 20, 2025, FH China Patient Network collaborated with Dr. Yang Fei, Director of the Department of Emergency Medicine at the First Hospital of Northwest University, to deliver...

On September 20, at the inaugural FH Conference, the 2025 Report of Psychosocial Status in individuals with HoFH was officially released. The study was jointly conducted by Homy FH China Patient Ne...

At 7:00 PM on September 19, on the eve of the 1st Chinese Conference on Familial Hypercholesterolemia,a special gathering called "Heart Bloom Lab" quietly began in a warm and relaxed atmosphere.Thi...